Literature DB >> 624286

Some properties of sialyltransferase in plasma and lymphocytes of patients with chronic lymphocytic leukemia.

D Kessel, T H Chou, J Allen.   

Abstract

Some properties of sialyltransferase activity in plasma and lymphocytes from patients with chronic lymphocytic leukemia were compared. Three distinct enzyme fractions were identified in plasma: (1) cation independent, irreversibly bound to agarose; (2) cation dependent, weakly bound to agarose; (3) strongly bound to agarose, lost upon dialysis. Lowering of the peripheral lymphocyte count by leukapheresis markedly decreased the level of serum sialyltransferase, suggesting the circulating lymphocyte is a source of the serum enzyme. The enzyme solubilized by detergent from lymphocytes showed a substantially lower Km for CMP-sialic acid than did the serum enzyme, was less sensitive to several inhibitors, was not irreversible bound to Agarose, and had a substantial cation requirement. The enzyme solubilized from the lymphocyte therefore generally resembles fraction 2 of serum.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624286     DOI: 10.1111/j.1432-1033.1978.tb12048.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Characterization of monoclonal antibodies to serum galactosyltransferase.

Authors:  D K Podolsky; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

2.  Sialyltransferase activity as a marker for the differentiation of lymphocytes. Increase in sialyltransferase activity of blasts from acute lymphoblastic leukaemia cases by 12-o-tetradecanoylphorbol-13-acetate (TPA).

Authors:  R Sasaki; F Takaku; Y L Lin; F J Bollum
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

3.  CUPRA-ZYME: An Assay for Measuring Carbohydrate-Active Enzyme Activities, Pathways, and Substrate Specificities.

Authors:  Zhixiong Li; Pavel I Kitov; Elena N Kitova; Fahima Mozenah; Emily Rodrigues; Digantkumar G Chapla; Kelley W Moremen; Matthew S Macauley; John S Klassen
Journal:  Anal Chem       Date:  2020-02-07       Impact factor: 6.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.